Nucleic Acid Therapy for β-Thalassemia
Annette d’Arqom1,2 1Graduate Program in Molecular Medicine, Faculty of Science, Mahidol University, Bangkok, Thailand; 2Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, IndonesiaCorrespondence: Annette d’Arqom Department of Pharmacolog...
Guardado en:
Autor principal: | d'Arqom A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12aafec9aea94e45aa9007931c5834ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Prithi Raguraman, et al.
Publicado: (2021) -
Nucleic acid therapeutics
Publicado: (2011) -
Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm
por: Wioleta Grabowska-Pyrzewicz, et al.
Publicado: (2021) -
The polarities of psychological well being and their response to treatment
por: Ruini,Chiara, et al.
Publicado: (2013) -
Cognitive Component in the Structure of Children’s Subjective Well-Being
por: Bruk Zh.Yu., et al.
Publicado: (2021)